0
Home Tags Exclusive

Tag: exclusive

Dr Nir Barzilai, Professor of Medicine and Genetics, predicts that rapamycin could decrease severity of coronavirus (COVID-19) in the elderly by 50%.
Features

COVID-19: Leading clinician calls for focus on the biology of aging

Danny Sullivan - 0
Investment

SyndicateRoom co-founder joins First Longevity

Danny Sullivan - 0
Investment

Longevity investment: Apollo aims for the moon

Danny Sullivan - 0
Biotech

Leading academic “profoundly disappointed” by COVID-19 response

Danny Sullivan - 0
Biotech

Exclusive interview: Professor Richard Faragher and cellular senescence

Danny Sullivan - 1
Axolotl’s Biosciences lead product, called ThinkInk, is a novel versatile bio-ink for bioprinting stem cell-derived neural tissues.
Innovation

New 3D bio-ink start-up targets neural tissue

Danny Sullivan - 0
The Forever Healthy Foundation published its latest analysis, focused on the use of dasatinib in conjunction with quercetin as a senolytic therapy.
Longevity TV

Video interview with Dr Isabelle Schiffer on senolytic safety

Danny Sullivan - 0
Braincures raising funds to target drug discovery for Alzheimer’s and other neurological diseases with data analysis and systems biological intelligence.
AI/Digital

Move over AI? Here comes biological intelligence

Danny Sullivan - 0
Marine biologist Dr Michèle Barbier is executive director at the Institute for Science & Ethics, which works to bring an ethical dimension to ocean science.
Biotech

Unlocking the Longevity potential of our oceans

Danny Sullivan - 0
Longevity AI
AI/Digital

Fountain’s ‘hypothesis-free’ approach to Longevity AI

Danny Sullivan - 0
123...8Page 1 of 8

LATEST ARTICLES

Leaps by Bayer leads $80m Series A to enable Cellino to significantly expand patient access to stem cell-based therapies.
Investment

Cellino bags $80 million to autonomise stem cell therapy manufacturing

Eleanor Garth - 0
Leaps by Bayer leads $80m Series A to enable Cellino to significantly expand patient access to stem cell-based therapies. Cellino Biotech, Inc, an autonomous stem cell...
Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic.

“World’s first” cultural-matching app for care sector launches

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration.

Biotech LyGenesis expands its liver regeneration tech

NURO embarks on funding round for neurotech communication system

    Subscribe to our newsletter

    Editor's picks

    Popular posts

    © Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY